Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 151 to 160 of 1514 total matches.
Zinc for the Common Cold
The Medical Letter on Drugs and Therapeutics • Jan 31, 1997 (Issue 993)
, Vol. 39 (Issue 993) January 31, 1997, pp. 9-10
Copyright The Medical Letter
UNAUTHORIZED ...
Results of a recent study suggested that zinc gluconate may be effective in treating the common cold (SB Mossad et al, Ann Intern Med, 125:81, July 15, 1996). Zinc gluconate lozenges, sometimes combined with vitamin C or other ingredients, are available in pharmacies and health food stores throughout the USA.
Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter on Drugs and Therapeutics • Jul 04, 1997 (Issue 1004)
effectiveness.
The Medical Letter, Vol. 39 (Issue 1004) July 4, 1997, pp. 61-62
Copyright The Medical Letter ...
Glatiramer acetate (Copaxone - Teva Marion Partners), formerly known as copolymer-l, has been approved by the US Food and Drug Administration (FDA) for treatment of relapsing-remitting multiple sclerosis (MS). Interferon β-1b (Betaseron) and interferon β-1a (Avonex - Medical Letter, 38:63, 1996) were previously approved for this indication.
Glucosamine for Osteoarthritis
The Medical Letter on Drugs and Therapeutics • Sep 26, 1997 (Issue 1010)
that has been reported to maintain
The Medical Letter, Vol. 39 (Issue 1010) September 26, 1997, pp. 91-92
Copyright ...
The Medical Letter has received many inquiries about use of glucosamine, a basic constituent of articular cartilage glycosaminoglycans, for treatment of arthritis. A recently published book (The Arthritis Cure), several television news shows, and articles in The New York Times have suggested it may be effective for treatment of osteoarthritis. Glucosamine is sold as a 'dietary supplement' in the USA.
Tamsulosin for Benign Prostatic Hyperplasia
The Medical Letter on Drugs and Therapeutics • Oct 10, 1997 (Issue 1011)
.
The Medical Letter, Vol. 39 (Issue 1011) October 10, 1997, p. 96
Copyright The Medical Letter
UNAUTHORIZED ...
Tamsulosin (Flomax - Boehringer Ingelheim), an alpha 1 - adrenoreceptor blocker, has been approved by the FDA for treatment of benign prostatic hyperplasia (BPH). It is claimed to bind preferentially to alpha1 receptors in the prostate.
Olopatadine for Allergic Conjunctivitis
The Medical Letter on Drugs and Therapeutics • Nov 21, 1997 (Issue 1014)
allergy-like symptoms are limited in effectiveness and may be irritating
The Medical Letter, Vol. 39 ...
Olopatadine hydrochloride (Patanol - Alcon), a propilidinedibenzoxypin derivative, has recently been marketed in a 0.1% ophthalmic solution for prevention of itching due to allergic conjunctivitis in adults and children more than three years old. It is the first drug for this indication that both inhibits mast cell degranulation and is a selective histamine H1 receptor antagonist (NA Sharif et al, J Pharmacol Exp Ther, 278:1252, 1996).
Arbutamine for Stress Testing
The Medical Letter on Drugs and Therapeutics • Jan 30, 1998 (Issue 1019)
(AR Shehata et al, Am J Cardiol, 80:716, 1997).
The Medical Letter, Vol. 40 (Issue 1019) January 30 ...
Myocardial perfusion imaging and stress echocardiography in patients who cannot exercise may require use of drugs. Arbutamine (GenESA - Gensia Automedics), a potent synthetic sympathomimetic, has recently been approved by the FDA for use with a computerized drug-delivery system in pharmacologic stress testing.
Raloxifene for Postmenopausal Osteoporosis
The Medical Letter on Drugs and Therapeutics • Mar 13, 1998 (Issue 1022)
to wholesale price (AWP) listings in First DataBank PriceAlert, February 15, 1998.
The Medical Letter, Vol. 40 ...
Raloxifene (Evista - Lilly), a benzothiophene that acts on estrogen receptors, has recently been marketed for prevention of postmenopausal osteoporosis. Only estrogen (alone or in combination with a progestin) and the bisphosphonate alendronate (Fosamax) were previously approved by the FDA for this indication.
Sibutramine for Obesity
The Medical Letter on Drugs and Therapeutics • Mar 13, 1998 (Issue 1022)
daily, blood pressure and heart rate permitting. The drug is available in 5-,
The Medical Letter, Vol ...
Sibutramine hydrochlorid monohydreate (Meridia - Knoll), which is structurally related to amphetamine, has been approved by the FDA for treatment of obesity. It is classified by the Drug Enforcement Agency (DEA) as a schedule IV controlled substance.
Dolasetron for Prevention of Nausea and Vomiting Due to Cancer Chemotherapy
The Medical Letter on Drugs and Therapeutics • May 08, 1998 (Issue 1026)
and carcinomas in mice.
The Medical Letter, Vol. 40 (Issue 1026) May 8, 1998, pp. 53-54
Copyright The Medical ...
Dolasetron (Anzemet - Hoechst Marion Roussel), a selective serotonin (5-HT3) receptor antagonist similar to ondansetron (Zofran) and granisetron (Kytril - Medical Letter, 36:61, 1994) is now available for both oral and intravenous use in prevention of nausea and vomiting due to cancer chemotherapy. A 5-HT3 antagonist plus dexamethasone (Decadron, and others) is the most effective regimen for prevention of acute vomiting caused by cancer chemotherapy. Dolasetron has also been approved by the FDA for prevention and treatment of postoperative nausea and...
Ginkgo Biloba for Dementia
The Medical Letter on Drugs and Therapeutics • Jun 19, 1998 (Issue 1029)
including 10,815 patients with dementia, only 183
The Medical Letter, Vol. 40 (Issue 1029) June 19, 1998 ...
Extracts made from leaves of the ginkgo tree (Ginkgo biloba) are available in the uSA as deitary supplements, in France and Germany as licensed drugs and worldwide as herbal remedies for treatment of dementia and many other indications.